128 related articles for article (PubMed ID: 34365583)
1. Pre-clinical evidence that salinomycin is active against retinoblastoma via inducing mitochondrial dysfunction, oxidative damage and AMPK activation.
Li J; Min Y
J Bioenerg Biomembr; 2021 Oct; 53(5):513-523. PubMed ID: 34365583
[TBL] [Abstract][Full Text] [Related]
2. Salinomycin ameliorates oxidative hepatic damage through AMP-activated protein kinase, facilitating autophagy.
Kim KY; Lee SG; Baek SY; Lee EH; Jang EJ; Lee JH; Ahn SC; Chang JH; Oh TW; Kim SH; Ma JY; Kim SC; Park KI; Kim YW
Toxicol Appl Pharmacol; 2018 Dec; 360():141-149. PubMed ID: 30290169
[TBL] [Abstract][Full Text] [Related]
3. The anti-malarial atovaquone selectively increases chemosensitivity in retinoblastoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Ke F; Yu J; Chen W; Si X; Li X; Yang F; Liao Y; Zuo Z
Biochem Biophys Res Commun; 2018 Oct; 504(2):374-379. PubMed ID: 29902460
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage.
Xiong Y; Liu W; Huang Q; Wang J; Wang Y; Li H; Fu X
Sci Rep; 2018 Aug; 8(1):11747. PubMed ID: 30082885
[TBL] [Abstract][Full Text] [Related]
5. Salinomycin activates AMP-activated protein kinase-dependent autophagy in cultured osteoblastoma cells: a negative regulator against cell apoptosis.
Zhu LQ; Zhen YF; Zhang Y; Guo ZX; Dai J; Wang XD
PLoS One; 2013; 8(12):e84175. PubMed ID: 24358342
[TBL] [Abstract][Full Text] [Related]
6. Artesunate targets oral tongue squamous cell carcinoma via mitochondrial dysfunction-dependent oxidative damage and Akt/AMPK/mTOR inhibition.
Xiao Q; Yang L; Hu H; Ke Y
J Bioenerg Biomembr; 2020 Apr; 52(2):113-121. PubMed ID: 31965456
[TBL] [Abstract][Full Text] [Related]
7. Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells.
Jangamreddy JR; Ghavami S; Grabarek J; Kratz G; Wiechec E; Fredriksson BA; Rao Pariti RK; Cieślar-Pobuda A; Panigrahi S; Łos MJ
Biochim Biophys Acta; 2013 Sep; 1833(9):2057-69. PubMed ID: 23639289
[TBL] [Abstract][Full Text] [Related]
8. Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.
Boehmerle W; Muenzfeld H; Springer A; Huehnchen P; Endres M
J Mol Med (Berl); 2014 Aug; 92(8):889-900. PubMed ID: 24770997
[TBL] [Abstract][Full Text] [Related]
9. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
10. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
[TBL] [Abstract][Full Text] [Related]
11. Salinomycin induces primary chicken cardiomyocytes death via mitochondria mediated apoptosis.
Gao X; Zheng Y; Ruan X; Ji H; Peng L; Guo D; Jiang S
Chem Biol Interact; 2018 Feb; 282():45-54. PubMed ID: 29331652
[TBL] [Abstract][Full Text] [Related]
12. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
[TBL] [Abstract][Full Text] [Related]
13. Early effects of the antineoplastic agent salinomycin on mitochondrial function.
Managò A; Leanza L; Carraretto L; Sassi N; Grancara S; Quintana-Cabrera R; Trimarco V; Toninello A; Scorrano L; Trentin L; Semenzato G; Gulbins E; Zoratti M; Szabò I
Cell Death Dis; 2015 Oct; 6(10):e1930. PubMed ID: 26492365
[TBL] [Abstract][Full Text] [Related]
14. Identification of DNA-PKcs as a primary resistance factor of salinomycin in osteosarcoma cells.
Zhen YF; Li ST; Zhu YR; Wang XD; Zhou XZ; Zhu LQ
Oncotarget; 2016 Nov; 7(48):79417-79427. PubMed ID: 27765904
[TBL] [Abstract][Full Text] [Related]
15. Salinomycin suppresses TGF-β1-induced EMT by down-regulating MMP-2 and MMP-9 via the AMPK/SIRT1 pathway in non-small cell lung cancer.
Hwang KE; Kim HJ; Song IS; Park C; Jung JW; Park DS; Oh SH; Kim YS; Kim HR
Int J Med Sci; 2021; 18(3):715-726. PubMed ID: 33437206
[TBL] [Abstract][Full Text] [Related]
16. Salinomycin: Anti-tumor activity in a pre-clinical colorectal cancer model.
Klose J; Trefz S; Wagner T; Steffen L; Preißendörfer Charrier A; Radhakrishnan P; Volz C; Schmidt T; Ulrich A; Dieter SM; Ball C; Glimm H; Schneider M
PLoS One; 2019; 14(2):e0211916. PubMed ID: 30763370
[TBL] [Abstract][Full Text] [Related]
17. Effects of salinomycin on human ovarian cancer cell line OV2008 are associated with modulating p38 MAPK.
Zhang B; Wang X; Cai F; Chen W; Loesch U; Bitzer J; Zhong XY
Tumour Biol; 2012 Dec; 33(6):1855-62. PubMed ID: 22773373
[TBL] [Abstract][Full Text] [Related]
18. Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress.
Ketola K; Hilvo M; Hyötyläinen T; Vuoristo A; Ruskeepää AL; Orešič M; Kallioniemi O; Iljin K
Br J Cancer; 2012 Jan; 106(1):99-106. PubMed ID: 22215106
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Autophagy Promotes Salinomycin-Induced Apoptosis via Reactive Oxygen Species-Mediated PI3K/AKT/mTOR and ERK/p38 MAPK-Dependent Signaling in Human Prostate Cancer Cells.
Kim KY; Park KI; Kim SH; Yu SN; Park SG; Kim YW; Seo YK; Ma JY; Ahn SC
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524116
[TBL] [Abstract][Full Text] [Related]
20. Salinomycin inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cell in vitro and suppresses tumor growth in vivo.
Wu D; Zhang Y; Huang J; Fan Z; Shi F; Wang S
Biochem Biophys Res Commun; 2014 Jan; 443(2):712-7. PubMed ID: 24333874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
